BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26639225)

  • 1. Non-inferiority and networks: inferring efficacy from a web of data.
    Lin J; Gamalo-Siebers M; Tiwari R
    Pharm Stat; 2016; 15(1):54-67. PubMed ID: 26639225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products.
    Gamalo MA; Tiwari RC; LaVange LM
    Pharm Stat; 2014; 13(1):25-40. PubMed ID: 23913880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The network meta-analytic-predictive approach to non-inferiority trials.
    Schmidli H; Wandel S; Neuenschwander B
    Stat Methods Med Res; 2013 Apr; 22(2):219-40. PubMed ID: 22218367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approach to non-inferiority trials for normal means.
    Gamalo MA; Wu R; Tiwari RC
    Stat Methods Med Res; 2016 Feb; 25(1):221-40. PubMed ID: 22619277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
    Ghosh S; Ghosh S; Tiwari RC
    Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues on the selection of non-inferiority margin in clinical trials.
    Hou Y; Wu XY; Li K
    Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evidential approach to non-inferiority clinical trials.
    Wang SJ; Blume JD
    Pharm Stat; 2011; 10(5):440-7. PubMed ID: 21928286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of non-inferiority mortality trials in oncology.
    Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
    Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and regulatory experiences with non-inferiority trial design without placebo arm.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2009 Apr; 51(2):324-34. PubMed ID: 19358213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.
    Koopmeiners JS; Hobbs BP
    Stat Methods Med Res; 2018 May; 27(5):1547-1558. PubMed ID: 27587591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing non-inferiority: a combination approach.
    Gao P; Ware JH
    Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ABC of non-inferiority margin setting from indirect comparisons.
    Julious SA
    Pharm Stat; 2011; 10(5):448-53. PubMed ID: 21928354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling the type 1 error rate in non-inferiority trials.
    Snapinn S; Jiang Q
    Stat Med; 2008 Feb; 27(3):371-81. PubMed ID: 17914715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials and tribulations of non-inferiority: the ximelagatran experience.
    Kaul S; Diamond GA; Weintraub WS
    J Am Coll Cardiol; 2005 Dec; 46(11):1986-95. PubMed ID: 16325029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing a non-inferiority study in kidney transplantation: a case study.
    Witte S; Schmidli H; O'Hagan A; Racine A
    Pharm Stat; 2011; 10(5):427-32. PubMed ID: 21928323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events.
    Aupiais C; Alberti C; Schmitz T; Baud O; Ursino M; Zohar S
    BMC Med Res Methodol; 2019 Sep; 19(1):187. PubMed ID: 31533631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.